SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-050863
Filing Date
2008-08-07
Accepted
2008-08-07 16:05:48
Documents
8
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-18599_110q.htm 10-Q 895400
2 EX-10.5 a08-18599_1ex10d5.htm EX-10.5 81030
3 EX-10.40 a08-18599_1ex10d40.htm EX-10.40 47287
4 EX-10.41 a08-18599_1ex10d41.htm EX-10.41 45153
5 EX-10.42 a08-18599_1ex10d42.htm EX-10.42 38485
6 EX-31.1 a08-18599_1ex31d1.htm EX-31.1 12884
7 EX-31.2 a08-18599_1ex31d2.htm EX-31.2 13606
8 EX-32 a08-18599_1ex32.htm EX-32 11482
  Complete submission text file 0001104659-08-050863.txt   1146811
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 08998602
SIC: 2834 Pharmaceutical Preparations